2024
SPIKENET: An Evidence-Based Therapy for Long COVID
Elumalai N, Hussain H, Sampath N, Shamaladevi N, Hajjar R, Druyan B, Rashed A, Ramamoorthy R, Kenyon N, Jayakumar A, Paidas M. SPIKENET: An Evidence-Based Therapy for Long COVID. Viruses 2024, 16: 838. PMID: 38932130, PMCID: PMC11209161, DOI: 10.3390/v16060838.Peer-Reviewed Original ResearchCarcinoembryonic antigen-related cell adhesion molecule 1Murine hepatitis virus-1Post-acute sequelae of COVID-19SARS-CoV-2 variantsSARS-CoV-2Development of severe inflammationCell adhesion molecule 1Long-term complicationsAdhesion molecule 1Multiple organ damagePotential therapeutic benefitMultiple SARS-CoV-2 variantsEvidence-based therapiesSequelae of COVID-19ACE2 receptor-binding domainSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Severe inflammationTissue edemaOrgan damageRespiratory syndrome coronavirus 2Long COVIDMolecule 1Receptor-binding domainSyndrome coronavirus 2
2023
A Mouse Model of MHV‐1 Virus Infection for Study of Acute and Long COVID Infection
Masciarella A, Di Gregorio D, Ramamoorthy R, Hussain H, Jayakumar A, Paidas M. A Mouse Model of MHV‐1 Virus Infection for Study of Acute and Long COVID Infection. Current Protocols 2023, 3: e896. PMID: 37867460, PMCID: PMC10606938, DOI: 10.1002/cpz1.896.Peer-Reviewed Original ResearchConceptsSARS-CoV-2Pathological changesMouse modelTransgenic miceLong-term organ dysfunctionSARS-CoV-2 pathophysiologyIrreversible neurological complicationsPotential therapeutic interventionsAvailable human dataBiosafety level 2 laboratoryNon-human primatesBiosafety level 3 laboratoryNeurological complicationsOrgan dysfunctionAcute stageClinical symptomsLong-term effectsSevere casesClinical observationsViral infectionTherapeutic interventionsMHV-1Animal preparationsWeight lossBSL-3 laboratoryMaternal SARS-CoV-2, Placental Changes and Brain Injury in 2 Neonates
Benny M, Bandstra E, Saad A, Lopez-Alberola R, Saigal G, Paidas M, Jayakumar A, Duara S. Maternal SARS-CoV-2, Placental Changes and Brain Injury in 2 Neonates. Pediatrics 2023, 151: e2022058271. PMID: 37021494, PMCID: PMC10467358, DOI: 10.1542/peds.2022-058271.Peer-Reviewed Original ResearchConceptsSARS-CoV-2SARS-CoV-2 infectionBrain injuryFetal brainSevere acute respiratory syndrome coronavirus disease 2Detectable SARS-CoV-2 antibodiesMaternal SARS-CoV-2 infectionSARS-CoV-2-positive mothersLong-term neurodevelopmental sequelaeMaternal SARS-CoV-2SARS-CoV-2 antibodiesStromal cell-derived factor-1Sudden unexpected infant deathInfant brainCell-derived factor-1Fetal vascular malperfusionSevere parenchymal atrophyHypoxic-ischemic encephalopathyBlood inflammatory markersUnexpected infant deathEarly-onset seizuresHuman chorionic gonadotropinOxidative stress injuryMonths of ageSARS-CoV-2 nucleocapsid protein
2021
594 SARS-CoV-2 in pregnancy, placental fetal vascular malperfusion and the effect on fetal heart rate tracings
Colon-Aponte C, Saad A, Ndubizu C, Galli J, Ahn H, Abhari P, Cruz N, Cohen M, Covarrubias A, Potter J, Spiliopoulos M, Jayakumar A, Burkett G, Pahwa S, Paidas M, Sfakianaki A. 594 SARS-CoV-2 in pregnancy, placental fetal vascular malperfusion and the effect on fetal heart rate tracings. American Journal Of Obstetrics And Gynecology 2021, 224: s374. PMCID: PMC7848511, DOI: 10.1016/j.ajog.2020.12.615.Peer-Reviewed Original Research